Rays of Belief IPO Launches with 20% GMP: Explore Price Band, Lot Size, and Essential Details!
The Rays of Belief IPO has opened for subscription, giving investors a three-day window to submit their bids until September 3, 2026. This Rs 125-crore issue consists entirely of a fresh issue of 52.30 lakh shares, with a price band set at Rs 227-239 per share. Investors are able to bid in lots of 62 shares, with a minimum investment amounting to Rs 14,818 at the upper end of the price range. The share allotment is expected to be finalised on September 4, with a tentative listing scheduled on both the NSE and BSE on September 8, 2026.
Current grey market sentiment surrounding the Rays of Belief IPO is optimistic, with the shares commanding a 20% Grey Market Premium (GMP). This translates to a premium of Rs 48 over the upper price of Rs 239, suggesting that investors anticipate a listing price around Rs 287. However, it’s important to note that GMP is an unofficial gauge and can fluctuate, hence it does not guarantee actual listing performance. This positive buzz could indicate strong demand among investors leading up to the listing.
For Indian investors, the Rays of Belief IPO presents an opportunity in a growing sector focused on educational and therapeutic services for children with neurodevelopmental disorders. Despite the company’s strong revenue growth of 125% year-on-year, a decline in profit signifies ongoing challenges in maintaining profitability. Investors should consider these dynamics alongside the positive sentiment reflected in the grey market, as the IPO could contribute to a more diversified portfolio while supporting a socially beneficial enterprise.
• WEALTHOVA INSIGHTS
Investors should closely monitor the IPO’s allocation and the eventual market response on listing day. The positive grey market sentiment may offer a lucrative entry point, provided the company can navigate its profitability challenges effectively.
Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)

